市場調查報告書

全球核醫學市場

Global Nuclear Medicine Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 909169
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球核醫學市場 Global Nuclear Medicine Market 2019-2025
出版日期: 2019年07月10日內容資訊: 英文
簡介

本報告提供全球核醫學市場的相關調查,提供市場機會,阻礙因素,各技術·療法·用途·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要及洞察

  • 報告的範圍
  • 分析師的洞察及目前市場趨勢
  • 規則及法規

第3章 競爭情形

  • 競爭儀表板
  • 主要策略分析
  • 主要企業分析
    • Cardinal Health,Inc.
    • Lantheus Medical Imaging,Inc.
    • Advanced Accelerator Applications SA
    • Jubilant Life Sciences Ltd.
    • General Electric Co.

第4章 市場決策要素

第5章 市場區隔

  • 各技術
  • 各療法
  • 各用途

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • Advanced Accelerator Applications S.A.
  • Bracco S.p.A
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler Group
  • General Electric Co.
  • Jubilant Life Sciences Ltd.
  • Karyopharm Therapeutics Inc.
  • Lantheus Medical Imaging, Inc.
  • Lucerno Dynamics, LLC
  • Nordion, a company of Sotera Health LLC
  • NorthStar Medical Radioisotopes, LLC
  • NTP Radioisotopes SOC Ltd.
  • Pharmalucence, Inc.
  • Positron Corp.
  • Rotem Industries Ltd.
  • Syntermed Inc.
目錄
Product Code: OMR2019773

Global Nuclear Medicine Size, Share & Trends Analysis Report by Technology (PET and SPECT) by Therapeutics (Alpha Emitters, Beta Emitters, and Brachytherapy), and by Application (Thyroid, Neurology, Oncology, Cardiology, and Others) and Forecast, 2019- 2025

Nuclear medicine is a branch of medicine that uses radioactive substances for the diagnosis and treatment of diseases. To study the disease progression and track the tissue function of the some of the chronic diseases such as neurological disorders, oncology, cardiovascular radioisotopes, the two widely known technologies used in nuclear medicine field includes Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). Increasing application of the radioisotopes for the development of the imaging scanners along with the rising prevalence of chronic disorders is propelling the growth of the global nuclear medicine market.

The global nuclear medicine market is segmented on the basis of technology, therapeutics, and application. In terms of technology, the market is bifurcated into PET and SPECT. Based on the therapeutics, the market is fragmented into alpha emitters, beta emitters, and brachytherapy. Furthermore, on the basis of application, the global market is segmented into the thyroid, neurology, oncology, cardiology, and others. Among these applications, the oncology segment is expected to hold a significant share in the nuclear medicine market. This is due to a rise in the application of the F-18 isotope for the treatment of cancer. The rise in prevalence of cancer across the globe is creating demand for the treatment and diagnostic devices, which in turn, is contributing to the segmental growth in the nuclear medicine market.

The global nuclear medicine market is segmented on the basis of geography into North America, Asia Pacific, Europe, and Rest of the World. North America accounts to contribute a considerable share in the nuclear medicine market due to the significant presence of investment groups that are investing huge amounts on the R&D sector of technologically advanced treatment procedures. Asia-Pacific is expected to witness lucrative growth in the nuclear medicine market during the forecast period. Increase in the incidence of cancer and cardiac disease in the region has encouraged the government and pharmaceutical companies in the development of effective solutions for the treatment of such chronic diseases.

The key players operating in the global nuclear medicine market include Cardinal Health, Inc., Curium Pharma, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., Jubilant Life Sciences Ltd., and General Electric Co. These market players are adopting various strategies to develop innovative solutions for the evolving nuclear medicine market. For instance, in June 2018, General Electric Co. has showcased software solutions and new molecular imaging in the Society of Nuclear Medicine and Molecular Imaging (SNMMI). This has benefited clinics in providing personalized, precise, and quantitative data.

RESEARCH METHODOLOGY

The market study of the global nuclear medicine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for nuclear medicine manufacturers and suppliers and government organization for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  • 1. Global Nuclear Medicine Market Research and Analysis by Technology
  • 2. Global Nuclear Medicine Market Research and Analysis by Therapeutics
  • 3. Global Nuclear Medicine Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global nuclear medicine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global nuclear medicine market.
  • Insights about market determinants which are stimulating the global nuclear medicine market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules &Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Cardinal Health, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. Swot Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Lantheus Medical Imaging, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. Swot Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Advanced Accelerator Applications S.A.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. Swot Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Jubilant Life Sciences Ltd.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. Swot Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. General Electric Co.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. Swot Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Nuclear Medicine Market by Technology
    • 5.1.1. Positron Emission Tomography (PET)
    • 5.1.2. Single Photon Emission Computed Tomography (SPECT)
  • 5.2. Global Nuclear Medicine Market by Therapeutics
    • 5.2.1. Alpha Emitters
    • 5.2.2. Beta Emitters
    • 5.2.3. Brachytherapy
  • 5.3. Global Nuclear Medicine Market by Application
    • 5.3.1. Thyroid
    • 5.3.2. Neurology
    • 5.3.3. Oncology
    • 5.3.4. Cardiology
    • 5.3.5. Others (Gastrointestinal)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Advanced Accelerator Applications S.A.
  • 7.2. Bracco S.p.A
  • 7.3. Cardinal Health, Inc.
  • 7.4. Curium Pharma
  • 7.5. Eckert & Ziegler Group
  • 7.6. General Electric Co.
  • 7.7. Jubilant Life Sciences Ltd.
  • 7.8. Karyopharm Therapeutics Inc.
  • 7.9. Lantheus Medical Imaging, Inc.
  • 7.10. Lucerno Dynamics, LLC
  • 7.11. Nordion, a company of Sotera Health LLC
  • 7.12. NorthStar Medical Radioisotopes, LLC
  • 7.13. NTP Radioisotopes SOC Ltd.
  • 7.14. Pharmalucence, Inc.
  • 7.15. Positron Corp.
  • 7.16. Rotem Industries Ltd.
  • 7.17. Syntermed Inc.

List of Tables

  • 1. GLOBAL NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 2. GLOBAL PET MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL SPECT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
  • 5. GLOBAL ALPHA EMITTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL BETA EMITTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 9. GLOBAL THYROID MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 15. NORTH AMERICAN NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. NORTH AMERICAN NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 17. NORTH AMERICAN NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
  • 18. NORTH AMERICAN NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 19. EUROPEAN NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 20. EUROPEAN NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 21. EUROPEAN NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
  • 22. EUROPEAN NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 23. ASIA-PACIFIC NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 24. ASIA-PACIFIC NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
  • 26. ASIA-PACIFIC NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 27. REST OF THE WORLD NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 28. REST OF THE WORLD NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
  • 29. REST OF THE WORLD NUCLEAR MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL NUCLEAR MEDICINE MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
  • 2. GLOBAL NUCLEAR MEDICINE MARKET SHARE BY THERAPEUTICS, 2018 VS 2025 (%)
  • 3. GLOBAL NUCLEAR MEDICINE MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 4. GLOBAL NUCLEAR MEDICINE MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 5. US NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. CANADA NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. UK NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. FRANCE NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. GERMANY NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ITALY NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. SPAIN NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. ROE NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. INDIA NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. CHINA NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. JAPAN NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
  • 17. REST OF THE WORLD NUCLEAR MEDICINE MARKET SIZE, 2018-2025 ($ MILLION)
Back to Top